A recent report published by
Infinium Global Research on high-content screening market provides in-depth
analysis of segments and sub-segments in global as well as regional
high-content screening market. The study also highlights the impact of drivers,
restraints and macro indicators on the global and regional high-content
screening market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of global
high-content screening market. According to the report, the global high-content
screening market is projected to grow at a CAGR of 10.1% over the forecast
period of 2018-2024.
High-content screening also known
as high-content analysis or high-content imaging is imaging technique, which
measures biochemical and physical characteristics in organism and cells. High-content
screening includes software which capturing images, evaluates them and stores
the information. This technique usually used in drug discovery and biological
research. High-content screening involves the use of a simultaneous recording
of multiple parameters in cell-based assays.
Latest Development in the
high-content screening (HCS) technology and its significance in drug discovery
is the major key factor fuelling the growth of high-content screening market.
Recent developments in cellular assay technologies like the introduction of
three-dimensional (3D) cultures and genome editing technologies have a positive
impact on drug discovery. Moreover, rising focus on biological research, the
rise in emphasis on diagnosis, the introduction of several new products by the
players in this market are the factors creating significant growth for the high-content
screening market. Rising application of high-content screening across several
sectors such as educational institutions, government organizations,
pharmaceutical, and healthcare have anticipated a boost to market growth.
However, a high price of high contents screening instruments is expected to
restrain the growth of high-content screening market. Growing government
funding helps to research and development for drug discovery is open up new
opportunities for the high-content screening market over the forecast period.
On the basis of geography, North America
accounted for the largest market share in the year 2017 followed by Europe.
Growing government support and rising investment in the research and
development activities are some of the supporting factors boosting the market
in this region. The Asia-Pacific and Europe are anticipated to be growing at
the fastest rate due to growing awareness about is its application in the field
of pharmaceutical and healthcare. The countries such as China and India are
projected to grow at a substantial growth, owing to rising research and
development activities are undertaken by the manufacturers to improve the cell
analyzers.
The report on global high-content screening market covers segments such as application, end user and product. On the basis of application, the global high-content screening market is categorized into the explorative screening, neurobiology, toxicology, oncology, target validation, and others. On the basis of the end user, the global high-content screening market is categorized into pharmaceutical and healthcare, biotechnology, educational institutions, independent CRO, government organizations, and others. On the basis of product, the global high-content screening market is categorized into accessories, consumables, software, services, instruments, reagents and others.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-Pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global high-content screening market such as Merck Millipore, Bio-Rad Laboratories, Inc., Tecan Group Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Perkinelmer, Inc., BioTek Instruments, Inc., GE Healthcare and Cell Signalling Technologies, Inc.
The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global high-content screening market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of high-content screening market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the high-content screening market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the high-content screening market to understand the present and future trends in this market and formulate their strategies accordingly.
Please Choose One of them.